News

April 24, 2019

Radiation, Hormone Therapy Extend Survival in Advanced PC, Phase 3 Trial Shows

News

A combination of androgen deprivation therapy (ADT) and external beam radiation therapy (EBRT) is better at delaying disease progression and extending survival of patients with locally advanced prostate cancer ... Read more

April 22, 2019

68Ga-PSMA-11 PET Scan Accurate, Safe in Detecting Recurrent PC, Study Says

News

68Ga-PSMA-11 PET scans are highly accurate, reproducible, and safe for detecting prostate cancer that has come back after prior therapy with prostate surgery or radiation therapy, a study shows. ... Read more

April 18, 2019

Liquid Biopsy Test Helping Select People with Advanced Prostate Cancer for Phase 2 Study of Pamiparib

News

A Phase 2 trial testing the investigational PARP inhibitor pamiparib in treating metastatic castration-resistant prostate cancer patients is using Epic Sciences‘ novel liquid biopsy assay to select those patients who ... Read more

April 17, 2019

Bucking Landmark U.S. Recommendation, Oncologist Urges PSA Screening

News

Despite a United States Preventive Services Task Force (USPSTF) 2012 conclusion that routine tests for prostate cancer are unnecessary, a prominent oncologist believes such screenings should be encouraged. Vladimir ... Read more

April 15, 2019April 15, 2019

Prostate Cancer’s Risk and Mortality Rates Dropping or Stabilizing in Most Countries, 5-Year Data Shows

News

Prostate cancer’s incidence and deadliness has declined or stabilized in much of the world in recent years, with the greatest decrease in risk evident in the U.S., a study ... Read more

April 11, 2019

ADXS-PSA/Keytruda Combo Prolongs Survival in mCRPC, Early Trial Results Suggest

News

Adding ADXS-PSA, an investigational cancer vaccine, to Keytruda (pembrolizumab) is showing positive signs of safety and efficacy in patients with metastatic, castration-resistant prostate cancer (mCRPC), and appears to prolong ... Read more

April 10, 2019

Web-based PREDICT Prostate Tool Provides Personalized Cancer Prognosis

News

A new web-based tool, called PREDICT Prostate, incorporates patients’ clinical and demographic data to provide a personalized prognosis to men with prostate cancer, helping them choose between radical treatment ... Read more

April 8, 2019

Prostate Cancer Foundation Announces Scholar-in-Training Award Winners

News

The Prostate Cancer Foundation (PCF) has announced the winners of the Scholar-in-Training Awards — research grants to support young scientists who presented outstanding data in the field of prostate ... Read more

April 4, 2019

2 Compounds in Coffee Seen to Slow Growth of Prostate Cancer in Early Study

News

Two compounds found in coffee might be able to slow the growth and migration of prostate cancers, a pilot study conducted in drug-resistant cancer cells and a mouse model ... Read more

April 3, 2019

Radioactive Compound Shows Promise as Therapy for Metastatic Castration-resistant Prostate Cancer Patients

News

Treatment with the radioactive molecule lutetium-177-PSMA-617 (LuPSMA), which binds to the prostate-specific membrane antigen, is a potential therapeutic strategy for patients with metastatic castration-resistant prostate cancer (CRPC), results from ... Read more

Pin It on Pinterest